LCID
Lucid Group, Inc.
LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
TRON
Tron Inc.
There isn't enough reported data to score TRON yet.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TRON Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Unavailable | |
| Weak |
TRON's revenue is currently healthy, but its profitability and balance sheet are weak. There isn't enough data to rate its cash flow.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
TRON PE Valuation
TRON has no meaningful PE right now: it lost money over the past year.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TRON Forward outlook
There aren't enough analyst estimates for TRON to show an outlook.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
TRON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.08 | -$0.04 |
| Q2 2026 | -$0.07 | +$0.11 |
| Q1 2026 | -$0.07 | +$0.17 |
| Q4 2025 | -$0.16 | +$0.21 |
| Q3 2025 | -$0.04 | +$0.39 |
| Q2 2025 | -$0.18 | +$0.34 |
| Q1 2025 | -$0.24 | +$0.24 |
| Q4 2024 | -$0.37 | -$0.06 |
TRON has the edge over LCID on earnings, with more consistent year-over-year improvement.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over TRON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
TRON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.2M | +7.5% |
| Q2 2026 | $1.6M | +17% |
| Q1 2026 | $1.2M | +8.7% |
| Q4 2025 | $1.2M | +31% |
| Q3 2025 | $1.1M | +26% |
| Q2 2025 | $1.3M | -11% |
| Q1 2025 | $1.1M | +8.3% |
| Q4 2024 | $920.7K | -24% |
TRON's revenue has grown year over year for five quarters in a row: $1M last quarter, up 7.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -48% | +11 points |
| Q2 2026 | -34% | +21 points |
| Q1 2026 | -50% | N/A |
| Q4 2025 | -39% | N/A |
| Q3 2025 | -59% | N/A |
| Q2 2025 | -55% | -21 points |
| Q2 2024 | -35% | N/A |
| Q1 2023 | -1.4% | -0.8 points |
TRON has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has the stronger cash trend. Its trailing FCF is down 75% versus its history, compared with TRON at down 98%.
TRON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | -$1.2M | -$821.2K |
| Q4 2023 | -$354.1K | -$51.2K |
| Q1 2023 | -$179.9K | +$87.5K |
| Q4 2022 | -$302.9K | +$153.3K |
| Q3 2022 | $268.7K | +$552.5K |
| Q2 2022 | $0 | +$1.2M |
| Q1 2022 | -$267.5K | -$257.1K |
TRON has burned cash in most quarters: −$2M over the past year, against −$301,677 the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has the edge over TRON on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
TRON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +4.1M shares |
| 1 year | +112% | +252M shares |
| 3 years | +4776% | +466M shares |
TRON has 476M diluted shares, up 112% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | $3.7M |
| Q2 2021 | — |
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TRON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2023 | 8.7x | High |
| Q4 2022 | 6.9x | High |
| Q2 2022 | -9.1x | Net Cash |
TRON's net debt is about 8.7 years of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
TRON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 24.1 | Neutral |
TRON's weekly RSI is 47 (neutral) and its Stochastic is 24 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
TRON PE vs Consumer Cyclical Sector
TRON has no meaningful PE right now: it lost money over the past year.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
TRON has stronger trend alignment. LCID is above 0 of 5 weekly averages versus TRON above 1 of 4.
TRON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.35 | 6.7% above |
| 20 week MA | $1.49 | 3.4% below |
| 50 week MA | $1.65 | 13% below |
| 100 week MA | $2.14 | 33% below |
TRON has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 33% below its 100-week average.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
TRON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $2.10 | $1.55 | -26% |
| 2024 | $1.55 | $0.61 | -61% |
| 2025 | $0.61 | $1.44 | +136% |
| 2026 YTD | $1.44 | $1.44 | 0% |
TRON has the edge over LCID on returns for 2026, with the stronger performance.